Inge Derdelinckx

2.2k total citations
43 papers, 765 citations indexed

About

Inge Derdelinckx is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Inge Derdelinckx has authored 43 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 13 papers in Epidemiology and 12 papers in Virology. Recurrent topics in Inge Derdelinckx's work include HIV/AIDS Research and Interventions (15 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (11 papers). Inge Derdelinckx is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (11 papers). Inge Derdelinckx collaborates with scholars based in Belgium, Netherlands and United States. Inge Derdelinckx's co-authors include Anne–Mieke Vandamme, Kristel Van Laethem, Eric Van Wijngaerden, Philippe Lemey, Willy Peetermans, Joke Snoeck, Andrew Rambaut, Yoeri Schrooten, Charles A. Boucher and David van de Vijver and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Inge Derdelinckx

40 papers receiving 750 citations

Peers

Inge Derdelinckx
Inge Derdelinckx
Citations per year, relative to Inge Derdelinckx Inge Derdelinckx (= 1×) peers Manuel Fernández Guerrero

Countries citing papers authored by Inge Derdelinckx

Since Specialization
Citations

This map shows the geographic impact of Inge Derdelinckx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Derdelinckx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Derdelinckx more than expected).

Fields of papers citing papers by Inge Derdelinckx

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Derdelinckx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Derdelinckx. The network helps show where Inge Derdelinckx may publish in the future.

Co-authorship network of co-authors of Inge Derdelinckx

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Derdelinckx. A scholar is included among the top collaborators of Inge Derdelinckx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Derdelinckx. Inge Derdelinckx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vles, Georges, et al.. (2024). Brucella melitensis periprosthetic joint infection:. Acta Orthopaedica Belgica. 90(4). 759–767.
2.
Florence, Éric, Michel Moutschen, Jean Cyr Yombi, et al.. (2021). Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology. 93(5). 2971–2978. 8 indexed citations
3.
Jacobs, Kenneth, Annette Schuermans, Johan Van Eldere, et al.. (2020). Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program. Infection. 48(3). 357–366. 38 indexed citations
4.
Derdelinckx, Inge, et al.. (2018). Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?. Infection. 47(2). 169–181. 36 indexed citations
5.
Desmet, Stefanie, Katrien Lagrou, Inge Derdelinckx, et al.. (2016). Cladophialophora bantiana osteomyelitis in a renal transplant patient. Medical Mycology Case Reports. 12. 17–20. 10 indexed citations
6.
Munter, Paul De, Inge Derdelinckx, Jan Verhaegen, et al.. (2015). Characteristics, causes, and outcome of 54 episodes of bloodstream infections in a cohort of HIV patients. Infectious Diseases. 47(9). 611–617. 8 indexed citations
7.
Vrancken, Bram, Andrew Rambaut, Marc A. Suchard, et al.. (2014). The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates. PLoS Computational Biology. 10(4). e1003505–e1003505. 63 indexed citations
8.
Depypere, Melissa, Jan Verhaegen, Inge Derdelinckx, & Wouter Meersseman. (2013). A FORGOTTEN DISEASE IN A RETURNING TRAVELER FROM THAILAND. Acta Clinica Belgica. 68(5). 382–383. 3 indexed citations
9.
Brenner, Stefanie S., et al.. (2012). Pharmacokinetics of the CGRP-receptor antagonist BI44370 during and between migraine attacks. British Journal of Clinical Pharmacology. 73(2). 320–320.
10.
Koole, Michel, Guy Bormans, Jan de Hoon, et al.. (2012). Tracer kinetic modeling of [C-11]JNJ42491293, a PET ligand for the mGluR2 receptor in the human brain. Journal of Cerebral Blood Flow & Metabolism. 32. 1 indexed citations
11.
Vijver, David van de, Inge Derdelinckx, & Charles A. Boucher. (2009). Circulating HIV Type 1 Drug Resistance Will Have Limited Impact on the Effectiveness of Preexposure Prophylaxis among Young Women in Zimbabwe. The Journal of Infectious Diseases. 199(9). 1310–1317. 20 indexed citations
12.
Hamers, Raph L, Rob Schuurman, Michèle van Vugt, Inge Derdelinckx, & Tobias F. Rinke de Wit. (2007). [AIDS treatment in Africa: the risk of antiretroviral resistance].. PubMed. 151(48). 2666–71. 2 indexed citations
13.
Lemey, Philippe, Sonia Van Dooren, Kristel Van Laethem, et al.. (2005). Molecular testing of multiple HIV-1 transmissions in a criminal case. AIDS. 19(15). 1649–1658. 32 indexed citations
14.
Snoeck, Joke, Kristel Van Laethem, Philippe Hermans, et al.. (2004). Rising Prevalence of HIV-1 Non-B Subtypes in Belgium: 1983???2001. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3). 279–285. 44 indexed citations
15.
Abecasis, Ana, Perpétua Gómes, Inge Derdelinckx, et al.. (2003). L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients. Antiviral Therapy. 8(3). 3 indexed citations
16.
Derdelinckx, Inge, Kristel Van Laethem, Bart Maes, et al.. (2003). Performance of the VERSANT®HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunology & Medical Microbiology. 39(2). 119–124. 9 indexed citations
17.
Snoeck, Joke, Sonia Van Dooren, Kristel Van Laethem, et al.. (2002). Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. Virus Research. 85(1). 95–107. 37 indexed citations
18.
Derdelinckx, Inge, Kristien Van Vaerenbergh, Sabina De Geest, et al.. (2001). Baseline resistance is significantly associated with long-term therapy response, especially in non-adherent patients. Antiviral Therapy. 6. 74. 3 indexed citations
19.
Vaerenbergh, Kristien Van, Inge Derdelinckx, Nancy De Cabooter, et al.. (2001). Retrospective analysis of therapy response to the initial therapy in 91 treatment-naive HIV-1 patients with and without baseline resistance mutations as measured by LiPA. Antiviral Therapy. 6. 96. 1 indexed citations
20.
Derdelinckx, Inge, Alex Maes, Jan Bogaert, Luc Mortelmans, & Daniël Blockmans. (2000). Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiologica. 55(3). 193–195. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026